Türk İlaç reports participation-finance screening ratios for 2026
The company’s non-consolidated six-month filing lists non-compliant income at 2.09%, assets at 0.19% and debt at 47.1%.
Key takeaways
- The six-month form reports non-compliant income of 2.09%.
- The form lists non-compliant assets at 0.19% and non-compliant debt at 47.1%.
Türk İlaç ve Serum Sanayi reported non-compliant income of 2.09%, non-compliant assets of 0.19% and non-compliant debt of 47.1% in its KAP participation-finance form. The figures cover the first six months of 2026 and use unconsolidated financial statements in Turkish lira.
The company answered no to questions about directly prohibited activities, incompatible provisions in its articles of association and share privileges. The form nevertheless records non-compliant income and balance-sheet ratios under its criteria.
For shareholders, the filing provides a screening of financial items against participation-finance principles; it does not report a new operational or ownership change.
This article was produced with the help of AI technology. Source: Yahoo Finance
